© 2026 WUKY
background_fid.jpg
Donate
Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations
Dr. Greg Davis on Medicine Podcast graphic with stethoscope
Dr. Greg Davis on Medicine

New immunotherapy treatment offering fresh hope for Kentucky cancer patients

By Greg Davis
Published March 4, 2026 at 5:00 AM EST
Ways To Subscribe
Markey medical oncologist Zhonglin Hao is leading a clinical trial for ZG006, a more powerful successor to FDA-approved immunotherapy that could help small cell lung cancer patients who’ve run out of options.
Photo by Shaun Ring
Markey medical oncologist Zhonglin Hao is leading a clinical trial for ZG006, a more powerful successor to FDA-approved immunotherapy that could help small cell lung cancer patients who’ve run out of options.

The University of Kentucky Markey Cancer Center has treated the first patient in the U.S. with a new immunotherapy for small cell lung cancer, offering hope for patients whose cancers have stopped responding to other treatments. Dr. Greg talks with Markey Cancer Center medical oncologist Zhonglin Hao, M.D., Ph.D.

Show links:

https://uknow.uky.edu/uk-healthcare/markey-cancer-center-treats-1st-patient-us-new-lung-cancer-therapy

https://medicine.uky.edu/users/zha245

Dr. Greg Davis on Medicine
Greg Davis
Dr. Greg Davis is a forensic pathologist with UK HealthCare. Every week, Davis speaks with local health providers, professionals, and researchers on Dr. Greg Davis on Medicine.
See stories by Greg Davis